Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.

@article{Davidson2007ParkinsonsDT,
  title={Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.},
  author={D. Fraser Davidson and Katherine Anne Grosset and Donald G. Grosset},
  journal={Annals of clinical biochemistry},
  year={2007},
  volume={44 Pt 4},
  pages={364-8}
}
BACKGROUND L-dopa is an important antiparkinsonian drug. It is a precursor of dopamine and the other catecholamines. Potentially, administration of L-dopa could lead to increased urinary excretion of catecholamines and their metabolites to abnormal amounts. The current study aimed to determine these excretions in patients with Parkinson's disease (PD) receiving L-dopa compared with suitable controls. This is the first assessment of the effect of exogenous administration of L-dopa on urinary… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…